bacillu
licheniformi
b
licheniformi
commonli
use
probiot
secondari
metabolit
attract
antimicrobi
candid
present
studi
aim
evalu
antivir
activ
crude
extract
b
licheniformi
porcin
epidem
diarrhea
viru
pedv
highli
contagi
envelop
porcin
viru
caus
great
econom
loss
pig
vivo
pedvinfect
piglet
supplement
airdri
solid
state
ferment
cultiv
contain
b
licheniformisfer
product
blfp
show
milder
clinic
symptom
decreas
viral
shed
importantli
signific
system
patholog
lesion
reduct
averag
daili
gain
note
pig
supplement
blfp
suggest
safe
use
pig
vitro
experi
reveal
b
licheniformi
crude
extract
exhibit
toxic
vero
cell
cocultiv
b
licheniformi
crude
extract
pedv
significantli
reduc
viral
infect
replic
summar
current
result
suggest
b
licheniformisfer
product
could
novel
candid
food
addit
reduc
impact
ped
swine
industri
permit
unrestrict
use
distribut
reproduct
medium
provid
give
appropri
credit
origin
author
sourc
provid
link
creativ
common
licens
indic
chang
made
begin
outbreak
new
variant
porcin
epidem
diarrhea
viru
pedv
caus
high
mortal
morbid
piglet
lead
great
econom
loss
lee
viru
caus
porcin
epidem
diarrhea
ped
character
wateri
diarrhea
vomit
sever
dehydr
pig
age
especi
suckl
piglet
lee
song
park
highli
contagi
diseas
spread
quickli
porcin
industri
sever
countri
jung
saif
lee
furthermor
pedv
infect
caus
sever
perturb
gut
microbiota
reduc
probiot
bacteri
abund
enrich
pathogen
bacteria
even
impair
growth
perform
pedvsurviv
pig
alvarez
et
al
depe
song
et
al
develop
effect
protect
agent
pedv
infect
urgent
need
probiot
one
choic
altern
antibiot
growth
promot
agp
abudabo
et
al
recent
studi
report
lactobacillu
speci
clostridium
butyricumfer
probiot
product
allevi
diarrhea
incid
reduc
gut
pathogen
wean
piglet
hand
bacillu
subtili
b
subtili
b
licheniformisfer
product
could
increas
growth
perform
mitig
clostridium
perfringensinduc
necrot
enter
broiler
cheng
et
al
lin
et
al
enhanc
nutrient
digest
lactobacillu
count
fece
feed
b
subtili
b
licheniformi
also
report
pig
lan
kim
demonstr
b
licheniformi
exhibit
antimicrobi
activ
pathogen
might
due
product
antibacteri
biosurfact
lin
et
al
furthermor
experi
result
also
demonstr
b
licheniformisfer
product
exhibit
antibacteri
activ
clostridium
perfringen
staphylococcu
aureu
vitro
lin
et
al
present
studi
antivir
effect
blfp
crude
extract
pedv
evalu
pig
surfactinlik
peptid
blfp
crude
extract
identifi
secondari
metabolit
b
licheniformi
ferment
cultiv
vitro
toxic
antivir
abil
surfactinlik
peptid
blfp
crude
extract
pedv
evalu
use
vero
cell
vero
cell
american
type
cultur
collect
atcc
maintain
dmem
gibco
ny
usa
supplement
fetal
bovin
serum
hyclon
utah
usa
penicillinstreptomycinamphotericin
b
gibco
ny
usa
passag
pedvpintung
strain
viral
stock
use
titer
tcid
ml
airdri
solidst
ferment
cultiv
b
licheniformi
weigmann
chester
atcc
suspend
distil
water
heat
min
supernat
harvest
centrifug
rpm
min
adjust
ph
valu
n
hcl
protein
precipit
precipit
dri
freez
dryer
wash
twice
distil
water
b
licheniformisfer
product
blfp
use
anim
studi
character
blfp
surfactin
deriv
bacillu
subtili
sigmaaldrich
st
loui
usa
use
standard
substanc
content
blfp
ferment
product
determin
highperform
liquid
chromatographi
hplc
previous
describ
schneider
marahiel
briefli
filtrat
sampl
subject
analysi
via
hplc
shimadzu
japan
prepack
lichrosph
column
merck
darmstadt
germani
mobil
phase
mixtur
mm
trifluoroacet
acid
ml
ddw
ml
methanol
elut
perform
flow
rate
mlmin
determin
uv
detector
vp
shimadzu
tokyo
japan
nm
gradient
strategi
follow
min
min
keep
b
acetonitril
b
ultrapur
water
min
pressur
bar
max
pressur
bar
pressur
stabil
bar
inject
volum
syring
speed
flush
volum
liquid
chromatographymass
spectrometri
lcm
full
scan
posit
mode
perform
mz
rang
fifteen
pedvfec
rna
pedv
seroneg
larg
white
duroc
crossbr
pig
acquir
convent
pig
farm
known
histori
ped
treatment
control
n
pedv
n
pedv
blfp
n
pig
fed
commerci
diet
mix
without
kgl
blfp
feed
addit
day
prior
viral
challeng
challeng
without
tcid
virul
week
age
tabl
group
hous
separ
fenc
area
clinic
symptom
fecal
consist
score
fecal
viral
shed
record
test
daili
clinic
score
record
use
normal
fece
pasti
semifluid
fluid
piglet
weigh
weekli
sacrif
day
postinfect
dpi
safeti
assess
patholog
examin
anim
experi
approv
institut
anim
care
use
committe
nation
taiwan
univers
taipei
taiwan
realtim
quantit
rtpcr
qpcr
perform
base
previous
describ
method
modif
chang
et
al
viral
rna
extract
cultur
supernat
use
cador
pathogen
qiacub
qiagen
chatsworth
ca
usa
accord
manufactur
instruct
revers
transcript
perform
use
quantinova
revers
transcript
kit
qiagen
accord
manufactur
protocol
qpcr
assay
quantinova
probe
master
mix
fecal
swab
use
determin
genom
equival
ge
detect
limit
realtim
rtpcr
ge
dna
use
plasmid
encod
pedv
n
gene
standard
data
shown
pig
euthan
necropsi
perform
dpi
evalu
safeti
blfp
pig
repres
tissu
sampl
collect
fix
neutralbuff
formalin
process
routin
slice
section
stain
hematoxylin
eosin
histopatholog
observ
record
assess
blindli
one
veterinari
pathologist
evalu
cytotox
blfp
crude
extract
vitro
vero
cell
first
grown
micropl
corn
life
scienc
corn
ny
usa
densiti
cell
per
well
day
prior
experi
remov
cultur
supernat
tenfold
serial
dilut
blfp
crude
extract
pi
medium
dmem
supplement
tryptos
phosphat
broth
sigmaaldrich
mo
usa
yeast
extract
acumedia
michigan
usa
trypsin
sigmaaldrich
mo
usa
ad
cell
monolay
h
cultur
supernat
remov
alamarblu
ad
gbioscienc
st
loui
usa
pb
h
incub
plate
read
excit
wavelength
nm
emiss
wavelength
nm
od
valu
well
calcul
obtain
percentag
reduct
alamarblu
accord
manufactur
instruct
addit
untreat
group
consist
vero
cell
without
treatment
includ
repres
reduct
alamarblu
data
calcul
percentag
untreat
group
normal
data
plot
concentr
blfp
crude
extract
fit
nonlinear
regress
curv
use
graphpad
prism
graphpad
softwar
san
diego
ca
cytotox
concentr
cc
concentr
blfpat
cellular
viabil
reduc
calcul
accordingli
studi
antivir
activ
blfp
crude
extract
pedv
biosurfact
ad
differ
time
point
viral
infect
vero
cell
seed
micropl
cellswel
day
experi
blfp
crude
extract
ppmin
pi
medium
ad
well
differ
order
treat
tcid
ml
pedv
infect
cell
experi
includ
five
group
illustr
fig
investig
antivir
mechan
postdrug
group
replic
kinet
pedv
vero
cell
without
crude
extract
blfp
compar
vero
cell
seed
micropl
cellswel
day
experi
crude
extract
blfp
ppm
pi
medium
ad
tcid
ml
pedvinfect
cell
cultur
supernat
cell
collect
separ
h
postinfect
viral
titer
cultur
supernat
determin
use
method
reed
express
tcid
ml
virusspecif
rna
cultur
supernat
cell
quantifi
realtim
revers
transcriptionpcr
viru
titrat
perform
cultur
supernat
briefli
first
dilut
subsequ
serial
dilut
supernat
ad
cellswel
vero
cell
micropl
h
incub
inocul
aspir
cell
wash
pi
medium
two
time
cultur
pi
medium
h
plate
subject
cytopath
effect
cpe
observ
titer
pedv
determin
use
method
reed
express
tcid
ml
determin
ic
vero
cell
seed
micropl
cellswel
one
day
experi
tenfold
serial
dilut
crude
extract
blfp
pi
medium
ad
vero
cell
h
tissu
cultur
infecti
dose
tcid
pedv
infect
h
percent
reduct
alamarbluestain
examin
alamarblu
assay
describ
normal
data
plot
fit
nonlinear
regress
curv
graphpad
prism
graphpad
softwar
gener
ic
elucid
direct
virucid
activ
crude
extract
blfp
pedv
viral
stock
titer
tcid
ml
mix
without
ppm
blfp
h
mixtur
serial
dilut
pi
medium
ad
vero
cell
h
viral
titer
determin
describ
data
analyz
plot
use
graphpad
prism
graphpad
softwar
error
bar
repres
standard
deviat
sd
signific
differ
among
group
cellbas
studi
determin
use
student
test
oneway
anova
tukey
multipl
comparison
pvalu
interpret
statist
signific
result
averag
daili
gain
adg
fecal
rna
shed
anim
experi
analyz
variabl
among
group
compar
use
nonparametr
kruskalw
test
p
consid
signific
data
analyz
use
graphpad
prism
softwar
graphpad
prism
inc
shown
fig
hplc
analysi
b
licheniformi
extract
show
singl
peak
fig
retent
time
min
ident
standard
substanc
surfactin
deriv
bacillu
subtili
fig
fig
assess
efficaci
antivir
abil
blfp
pedv
clinic
symptom
viral
challeng
record
daili
fig
fecal
condit
pig
group
score
normal
score
pedv
inocul
gener
pig
supplement
blfp
exhibit
milder
symptom
compar
piglet
supplement
control
control
group
five
pig
exhibit
normal
clinic
sign
score
studi
pedv
group
pig
supplement
control
food
differ
sever
pedvassoci
clinic
sign
first
detect
day
post
infect
dpi
two
five
pig
exhibit
semifluid
fece
score
dpi
pig
show
typic
semifluid
score
wateri
diarrhea
score
dpi
eventu
recov
dpi
pedv
blfp
group
pig
exhibit
pasti
fece
score
dpi
one
pig
exhibit
transient
typic
wateri
diarrhea
score
dpi
compar
pedvinfect
group
control
food
sever
durat
typic
diarrhea
score
reduc
pedv
blfp
group
quantifi
pedvassoci
fecal
viral
shed
evalu
antivir
efficaci
blfp
rtqpcr
use
detect
fecal
viral
shed
pedv
group
grey
line
fig
fecal
viral
shed
first
detect
log
ge
dpi
found
gradual
increas
peak
viral
load
log
ge
dpi
continu
detect
dpi
pedv
blfp
group
black
line
fig
pattern
viral
shed
similar
lower
inth
pedv
group
studi
although
differ
statist
signific
pig
weigh
weekli
order
evalu
growth
perform
without
biosurfact
feed
addit
signific
differ
averag
daili
gain
adg
pig
note
among
group
week
fig
b
fig
clinic
score
fecal
consist
compar
pedvinfect
group
appear
durat
typic
diarrhea
score
reduc
pedv
blfp
group
evalu
safeti
blfp
feed
addit
pig
necropsi
perform
piglet
week
postinfect
gross
histopatholog
examin
gross
histopatholog
examin
macroscop
microscop
lesion
note
group
find
suggest
blfp
feed
addit
kgton
safe
convent
pig
day
feed
determin
median
cytotox
concentr
cc
blfp
crude
extract
vero
cell
blfp
crude
extract
serial
dilut
ppm
ad
cell
h
postincub
hpi
cytotox
due
blfp
crude
extract
observ
vero
cell
fig
determin
maxim
inhibitori
concentr
postdrug
group
use
evalu
maxim
inhibitori
effect
blfp
crude
extract
cocultiv
fig
fecal
shed
detect
piglet
fed
kgton
blfp
group
n
pattern
viral
shed
pedv
blfp
group
similar
lower
pedv
group
studi
signific
differ
detect
chang
mean
valu
genom
equival
ge
ml
present
valu
sd
viral
rna
load
inocul
group
control
group
compar
use
nonparametr
kruskalw
test
fig
averag
daili
gain
pig
group
pig
weigh
weekli
order
evalu
growth
perform
without
blfp
feed
addit
static
signific
differ
averag
daili
gain
note
among
group
week
blfp
crude
extract
pedvinfect
cell
whole
studi
result
indic
antivir
activ
blfp
crude
extract
dosedepend
inhibit
pedvinduc
cpe
calcul
ic
valu
ppm
fig
elucid
antivir
activ
blfp
crude
extract
pedv
ppm
blfp
crude
extract
ad
cultur
differ
time
point
viral
infect
shown
fig
typic
pedvinduc
cpe
character
format
syncyti
cell
cell
death
detach
cultur
plate
pedvinfect
cell
percent
reduct
alamarblu
stain
treat
blfp
crude
extract
h
infect
time
infect
h
viral
infect
replac
fresh
pi
mediumwer
calcul
respect
show
signific
dosedepend
effect
blfp
crude
extract
pedv
halfmaxim
inhibitori
concentr
ic
blfp
crude
extract
pedv
vero
cell
ppm
data
present
mean
sd
three
test
replic
differ
pedvinfect
group
fig
postdrug
group
signific
inhibit
pedvinduc
cpe
reduct
alamarblu
stain
observ
compar
group
similarli
amount
viral
rna
supernat
rang
log
ge
significantli
lower
rang
log
ge
fig
addit
viral
titer
supernat
group
less
tcid
ml
lower
rang
tcid
ml
moreov
evalu
direct
virucid
activ
blfp
crude
extract
pedv
reduct
viral
titer
pedv
tcid
ml
observ
investig
antivir
mechan
postdrug
group
replic
kinet
pedv
vero
cell
presenc
absenc
blfp
crude
extract
determin
compar
pedvinfect
vero
cell
cultur
without
blfp
crude
extract
show
viral
titer
hpi
tcid
ml
hpi
fig
cell
treat
blfp
crude
extract
undetect
extracellular
viral
titer
significantli
lower
cell
without
blfp
crude
extract
similarli
extracellular
viral
rna
level
pedvinfect
cell
cultur
biosurfact
significantli
lower
without
blfp
crude
extract
hpi
fig
howev
signific
differ
intracellular
viral
titer
fig
intracellular
viral
rna
fig
note
pedvinfect
cell
treat
without
blfp
crude
extract
sinc
late
new
variant
pedv
identifi
sever
counti
caus
devast
diseas
econom
loss
viral
threat
prompt
global
effort
develop
antivir
new
variant
pedv
vitro
song
choi
kwon
et
al
vivo
cho
et
al
kim
et
al
herein
demonstr
blfp
crude
extract
present
cell
toxic
vero
cell
exhibit
signific
antivir
abil
vero
cell
biosurfact
cocultiv
pedv
piglet
supplement
blfp
concentr
kgton
less
exhibit
milder
clinic
symptom
lower
viral
shed
compar
piglet
supplement
control
food
blfp
caus
signific
toxic
therefor
blfp
suggest
promis
novel
feed
addit
act
addit
pedv
field
main
antivir
mechan
blfp
crude
extract
thought
relat
uniqu
biochem
structur
increas
membran
permeabl
disrupt
lyse
microbi
membran
huang
et
al
perform
directvirucid
studi
blfp
crude
extract
pedv
tenfold
reduct
viral
titer
abl
confirm
directedantivir
abil
blfp
crude
extract
accord
hplc
analysi
peak
surfactinlik
peptid
identifi
blfp
crude
extract
sever
differ
potenti
antivir
mechan
biosurfact
previous
report
vollenbroich
et
al
wang
et
al
lipopeptid
biosurfact
previous
suggest
possess
probiot
attribut
anim
human
use
schneider
sen
previou
studi
demonstr
antivir
abil
surfactin
b
subtili
achiev
competit
tgev
entri
receptor
inhibit
viral
enzym
protonatpas
requir
entri
virus
cell
surfactin
b
subtili
vollenbroich
et
al
also
report
worth
note
cocultiv
surfactinlik
peptid
blfp
crude
extract
pedvinfect
vero
cell
significantli
reduc
viral
infect
replic
studi
blfp
crude
extracttr
pedvinfect
cell
also
exhibit
undetect
extracellular
viral
titer
suggest
blfp
crude
extract
may
play
import
role
reduc
releas
virion
result
suggest
addit
mechan
blfp
crude
extract
pedv
vero
cell
although
studi
antivir
mechan
blfp
crude
extract
need
futur
observ
divers
antivir
activ
blfp
crude
extract
lead
develop
new
therapeut
candid
previou
studi
demonstr
lipopeptid
produc
variou
bacillu
spp
safe
mice
younhwan
hwang
et
al
wean
piglet
torr
et
al
administ
certain
concentr
order
use
blfp
feed
addit
antivir
properti
assess
antivir
safeti
profil
pig
essenti
result
demonstr
piglet
supplement
blfp
show
milder
symptom
fig
replic
kinet
pedv
vero
cell
treat
without
blfp
crude
extract
extracellular
viral
titer
supernat
pedvinfect
vero
cell
treat
without
blfp
crude
extract
determin
viral
titrat
vero
cell
use
method
express
tcid
ml
b
extracellular
viral
rna
level
supernat
pedvinfect
vero
cell
treat
without
blfp
crude
extract
determin
realtim
revers
transcript
rt
pcr
c
intracellular
viral
titer
pedvinfect
vero
cell
treat
without
blfp
crude
extract
determin
viral
titrat
vero
cell
intracellular
viral
rna
level
supernat
pedvinfect
vero
cell
treat
without
blfp
crude
extract
determin
realtim
rtpcr
statist
analysi
perform
use
student
ttest
statist
signific
differ
label
p
reduc
viral
shed
importantli
signific
system
patholog
effect
chang
averag
daili
gain
note
result
suggest
biosurfact
concentr
kgton
less
safe
pig
futur
applic
previou
studi
found
administr
surfactin
b
subtili
kgton
lead
necrosi
hepatocyt
rat
hwang
et
al
futur
anim
experi
use
higher
dosag
biosurfact
would
necessari
valid
maxim
safeti
dosag
present
studi
blfp
investig
antivir
candid
pedv
vitro
blfp
crude
extract
exhibit
antivir
activ
pedv
incub
longterm
pedvinfect
cell
vivo
first
valid
safeti
antivir
abil
blfp
feed
addit
less
kgton
pedv
long
period
pedv
inocul
result
suggest
blfp
could
novel
candid
feed
addit
reduc
titer
pedv
swine
industri
